Financhill
Buy
52

DNA Quote, Financials, Valuation and Earnings

Last price:
$10.13
Seasonality move :
-41.81%
Day range:
$8.65 - $10.23
52-week range:
$5.00 - $17.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.06x
P/B ratio:
1.09x
Volume:
2.7M
Avg. volume:
1M
1-year change:
-26.17%
Market cap:
$612M
Revenue:
$227M
EPS (TTM):
-$6.23

Earnings Data

Next earnings date for DNA
Feb 24
2026
Most recent earnings per share
-$1.45
Missed by $1.45
(Nov 6/2025)
Consensus Estimate
--
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $42.8M -- -- -- --
02/24/2026 Q4 $37.6M -- -- -$1.11 --
11/06/2025 Q3 $38.9M $38.8M -$1.45 -- --
08/07/2025 Q2 $41.6M $49.6M -$1.10 -- --
05/06/2025 Q1 $38.7M $48.3M -$1.68 -- --
02/25/2025 Q4 $44.4M $43.8M -$2.00 -$1.30 -$0.70
11/12/2024 Q3 $45M $89M -$1.08 -- --
08/08/2024 Q2 $43M $56.2M -$4.23 -- --
05/09/2024 Q1 $46M $37.9M -$3.31 -$3.20 -$0.11
02/29/2024 Q4 $42.6M $34.8M -$4.28 -$2.80 -$1.48
11/08/2023 Q3 $48.1M $55.4M -$6.21 -$3.20 -$3.01
08/09/2023 Q2 -- $80.6M -$3.59 -- --
05/10/2023 Q1 -- $80.7M -$4.29 -- --
03/01/2023 Q4 -- $98.3M -$3.81 -- --
11/14/2022 Q3 -- $66.4M -$16.44 -- --
08/15/2022 Q2 -- $144.6M -$16.51 -- --
05/16/2022 Q1 -- $168.4M -$14.69 -- --
03/28/2022 Q4 -- $148.5M -$39.73 -- --
11/15/2021 Q3 -- $77.6M -$2.74 -- --
06/30/2021 Q2 -- $43.6M -$1.67 -- --
03/31/2021 Q1 -- $44.1M -$2.28 -- --
12/31/2020 Q4 -- $32.1M -$1.46 -- --
09/30/2020 Q3 -- $13.3M -$0.70 -- --

Ginkgo Bioworks Holdings, Inc. Earnings Questions

  • How Much did Ginkgo Bioworks Holdings, Inc. Generate in Revenue Last Quarter?

    Ginkgo Bioworks Holdings, Inc. reported $38.8M worth of top line sales in its most recent quarter.

  • Did Ginkgo Bioworks Holdings, Inc. Beat Earnings Last Quarter?

    Ginkgo Bioworks Holdings, Inc. announced earnings per share of -$1.45 which represents a miss of analyst forecast a -- per share.

  • Is Ginkgo Bioworks Holdings, Inc. Profitable?

    Ginkgo Bioworks Holdings, Inc. reported $11.9M that represents $0.21 per share over the last quarter.

  • What is the Analyst Consensus for Ginkgo Bioworks Holdings, Inc. EPS Next Year?

    Ginkgo Bioworks Holdings, Inc.'s earnings are forecast to decrease from -$10.54 per share to -$5.34 per share next year representing a decrease of -65.56%.

  • When is Ginkgo Bioworks Holdings, Inc.'s Earnings Date?

    Ginkgo Bioworks Holdings, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock